Robots for diagnostics and surface sanitation, a chat-bot integrated into the MOH’s online portal for providing public consulting support during the pandemic, contactless terminal for body temperature measurement, pass control management platform to be...
Even in the most optimistic scenario, the coronavirus disease outbreak in the Russian Federation will last for at least two months, Georgii Bazykin, Skoltech Professor, Chair of the Molecular Evolution Sector, IITP RAS, believes According to his forecast...
Skolkovo resident company 3D Bioprinting Solutions has become the first company to use a 3D printer to create live tissue in space, printing an organ construct for the thyroid gland of a mouse on board the International Space Station (ISS) this month. ...
Rusbase, an independent website devoted to technology, business and investment, published a list on Tuesday of the top five most interesting biotech startups in Russia, and all are residents of the Skolkovo Foundation. An ExoAtlet pilot demonstrates the...
The Skolkovo Foundation has joined forces with the U.K.’s AMR Centre, a private-public initiative launched in 2016 to support and accelerate the development of new antibiotics, to combat the global problem of antimicrobial resistance. Skolkovo's...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
Russia’s first commercial research biobank, National BioService , opened a brand new laboratory at the Skolkovo Technopark on Thursday. The National BioService lab at the Skolkovo Technopark will be used for both the company's own research and...
The first shared lab space in Russia for life sciences and biotech startups opened its doors at the Skolkovo Technopark on Wednesday with a mission to help budding biomed entrepreneurs test their theories and turn their ideas into a commercial company. ...
Pharm-Sintez.Lab , a resident startup of the Skolkovo Foundation’s nuclear cluster, has developed a system for detecting rare forms of cancer in Russian patients. Lev Voloznev, CEO of Pharm-Sintez.Lab, pictured in his lab at the Skolkovo Technopark...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
SL Onkolodzhi , a Skolkovo resident startup working on a cancer vaccine, has successfully completed phase I/IIa clinical trials together with its U.S. partner, CureLab Oncology, Inc . The two companies have developed a cancer vaccine called Elenagen™...
Infectex , a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day. The drug – SQ109 – has demonstrated high...
Skolkovo startup DRD Biotech has produced a working prototype of an express test that can determine in just a few minutes whether a person has had – or is at near-term risk of having – the most common kind of stroke. Svetlana Dambinova has...
ExoAtlet , a Skolkovo startup that makes medical exoskeletons for the rehabilitation of disabled people, has started clinical research into the use of its exoskeletons to help people with multiple sclerosis. An ExoAtlet exoskeleton being demonstrated...
The Skolkovo Foundation has signed a cooperation agreement with BioCubaFarma, Cuba’s biggest biotech company, continuing a series of agreements and mutual visits between the foundation and the island nation. Prime Minister Dmitry Medvedev, right...
Finland’s BioCity Technopark is to build a biotech technopark at the Skolkovo innovation centre under an agreement signed Tuesday at the ongoing International Association of Science Parks and Areas of Innovation (IASP) conference in Moscow. Kirill...
Lake Baikal, the world’s oldest and deepest lake, is in danger. For several years now, the water near the shores of the vast Siberian lake has been turning green with algae, and satellite images reveal that that is only a small part of a much bigger problem...
If scientists invented an anti-ageing pill that would help you live to the age of 120, would you take it? Think carefully, because if it sounds like science fiction, it’s not. Ageing is a treatable disease like any other, according to some scientists...
As nations across the globe marked World Cancer Day on February 4, the Skolkovo Foundation announced the creation of a new Cancer Centre of Excellence. The new centre is set to coordinate the work of all the startup companies and partners currently working...
Skolkovo biomed cluster resident 3D Bioprinting Solutions has announced the successful printing of a mouse’s thyroid gland. 3D Bioprinting Solutions unveiled Russia's first bioprinter in October. Photo: 3D Bioprinting Solutions If confirmed...
Skolkovo resident biomed company Aelita has put a new anesthetic machine through five months of successful testing on real patients, passing a key test on the path to market entry. The machine, known as Anekom, is intended for inhalation anesthesia in combination...
A 30 million ruble grant from the Skolkovo Foundation is helping a team of Russian scientists develop potentially one of the most effective drugs yet to fight cardiovascular disease – the primary cause of death in Russia and the wider world. Dmitry...